Glovers Anti-dandruff Ointment
NDC Package 12022-009-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Glovers Anti-dandruff (sulfur, salicylic acid) ointment is apply a small amount to the scalp one to four times daily or as directed by a doctor. This formulation utilizes a ointment delivery system. Marketed by J. Strickland & Co., this product is identified by NDC 12022-009 and is authorized under FDA application M032.

Identification & Billing

NDC Package Code
12022-009-01
Package Description
99 g in 1 JAR
Product Code
12022-009
11-Digit Billing Format
12022000901
RxNorm Crosswalk
  • RxCUI: 247682 - salicylic acid 3 % / sulfur 5 % Topical Ointment
  • RxCUI: 247682 - salicylic acid 0.03 MG/MG / sulfur 0.05 MG/MG Topical Ointment

Clinical Specifications

Proprietary Name
Glovers Anti-dandruff
Non-Proprietary Name
Sulfur, Salicylic Acid
Substance Name
Salicylic Acid; Sulfur
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Apply a small amount to the scalp one to four times daily or as directed by a doctor

Regulatory & Marketing

Labeler Name
J. Strickland & Co.
Product Type
Human Otc Drug
FDA Application #
M032
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-20-2001
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (12022-009). Click a package code to view its specific billing and regulatory data.

12022-009-00
28 g in 1 JAR

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 12022-009-01 identifies a specific commercial package of 99 g in 1 jar of Glovers Anti-dandruff, a human over the counter drug labeled by J. Strickland & Co.. This ointment is formulated for topical use and contains salicylic acid; sulfur as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by J. Strickland & Co. on September 20, 2001. The current certification is valid through December 31, 2026.

How is this J. Strickland & Co. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 12022000901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
12022-009-01
11-Digit CMS (5-4-2)
12022-0009-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.